NO20041785L - Farmasoytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt - Google Patents

Farmasoytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt

Info

Publication number
NO20041785L
NO20041785L NO20041785A NO20041785A NO20041785L NO 20041785 L NO20041785 L NO 20041785L NO 20041785 A NO20041785 A NO 20041785A NO 20041785 A NO20041785 A NO 20041785A NO 20041785 L NO20041785 L NO 20041785L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
mycophenolic acid
mycophenolate salt
mycophenolate
salt
Prior art date
Application number
NO20041785A
Other languages
English (en)
Other versions
NO341804B1 (no
Inventor
Juergen Dederichs
Thomas Rigassi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9924043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20041785(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20041785L publication Critical patent/NO20041785L/no
Publication of NO341804B1 publication Critical patent/NO341804B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
NO20041785A 2001-10-17 2004-05-03 Fremgangsmåte for fremstilling av en farmasøytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt. NO341804B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds
PCT/EP2002/011589 WO2003032978A1 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt

Publications (2)

Publication Number Publication Date
NO20041785L true NO20041785L (no) 2004-05-03
NO341804B1 NO341804B1 (no) 2018-01-22

Family

ID=9924043

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041785A NO341804B1 (no) 2001-10-17 2004-05-03 Fremgangsmåte for fremstilling av en farmasøytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt.

Country Status (31)

Country Link
US (3) US20050013859A1 (no)
EP (1) EP1438040B2 (no)
JP (2) JP2005508959A (no)
KR (1) KR100671367B1 (no)
CN (1) CN1310640C (no)
AR (2) AR036813A1 (no)
AT (1) ATE374023T1 (no)
AU (1) AU2002338897B2 (no)
BR (1) BR0213355A (no)
CA (1) CA2460574A1 (no)
CO (1) CO5390076A1 (no)
CY (1) CY1107841T1 (no)
DE (1) DE60222687T3 (no)
DK (1) DK1438040T4 (no)
EC (2) ECSP024341A (no)
ES (1) ES2292819T5 (no)
GB (1) GB0124953D0 (no)
HU (1) HU231114B1 (no)
IL (2) IL160968A0 (no)
MX (1) MXPA04003636A (no)
MY (1) MY139206A (no)
NO (1) NO341804B1 (no)
NZ (1) NZ532280A (no)
PE (1) PE20030476A1 (no)
PL (2) PL234541B1 (no)
PT (1) PT1438040E (no)
RU (2) RU2338528C2 (no)
SI (1) SI1438040T2 (no)
TW (1) TWI333861B (no)
WO (1) WO2003032978A1 (no)
ZA (1) ZA200401977B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
JP2008506784A (ja) * 2004-07-20 2008-03-06 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 結晶形ミコフェノール酸・ナトリウム
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
WO2006086498A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
EP1917010A2 (en) * 2005-02-08 2008-05-07 Aspreva Pharmaceuticals SA Compositions and methods for treating vascular, autoimmune and inflammatory diseases
CA2623826A1 (en) * 2005-09-30 2007-04-12 Novartis Ag Dpp iv inhibitor for use in the treatment of autoimmune diseases and graft rejection
JP5394746B2 (ja) 2005-12-21 2014-01-22 ビーエーエスエフ ソシエタス・ヨーロピア 錠剤崩壊剤としての微粒子状架橋ポリビニルピロリドン
US20090023805A1 (en) * 2006-02-13 2009-01-22 Anne Claire Marrast Method of administration
EP2164462B1 (de) 2007-06-06 2017-05-31 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
EP2164460B1 (de) 2007-06-06 2017-08-09 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
RU2010109408A (ru) * 2007-08-13 2011-09-20 Панацея Биотек Лимитед (In) Композиции с пролонгированным высвобождением, включающие микофенолят натрия, и их действия
BRPI0909030A2 (pt) * 2008-03-05 2018-03-13 Panacea Biotec Ltd composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.
CA2729834A1 (en) * 2008-07-09 2010-01-14 Aspreva International Ltd. Formulations for treating eye disorders
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011046546A1 (en) * 2009-10-13 2011-04-21 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) * 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) * 2017-01-03 2017-05-31 无锡福祈制药有限公司 一种麦考酚钠肠溶片及其制备方法
CA3054817A1 (en) * 2017-03-13 2018-09-20 Okava Pharmaceuticals, Inc. Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
SG11202007172YA (en) 2018-06-06 2020-08-28 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
CA3103324A1 (en) * 2018-06-14 2019-12-19 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
WO2021252951A1 (en) 2020-06-12 2021-12-16 Vanderbilt University Methods of treatment for gastrointestinal motility disorders
AU2022214268A1 (en) * 2021-01-28 2023-07-27 Priothera Limited Methods of treatment with s1p receptor modulators
WO2022162409A1 (en) * 2021-01-28 2022-08-04 Priothera Sas Methods of treatment with s1p receptor modulators
WO2022250977A1 (en) * 2021-05-26 2022-12-01 The Texas A&M University System Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) * 2023-12-21 2024-04-05 泊诺(天津)创新医药研究有限公司 一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157100A (en) † 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US3705946A (en) * 1971-05-25 1972-12-12 Lilly Co Eli Method of treating hyperuricemia
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) * 1980-03-10 1981-10-05 Ajinomoto Co Inc Preparation of mycophenolic acid
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
EP0670724A1 (en) * 1992-11-24 1995-09-13 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
SK104895A3 (en) * 1993-02-26 1996-06-05 Procter & Gamble Pharmaceutical composition and its use
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
CZ301771B6 (cs) * 1993-10-01 2010-06-16 Syntex (U.S.A.) Llc. Farmaceutický prostredek ve forme suchého granulátu obsahující mofetil mykofenolát nebo kyselinu mykofenolovou a zpusob jeho prípravy
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
ATE474590T1 (de) * 1999-05-10 2010-08-15 Paolo Brenner Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen
HUP9903226A2 (en) * 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
DE60023187D1 (de) * 2000-02-29 2006-02-23 Biocon Ltd Herstellung und reinigung von mycophenolsäure
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
AR085778A2 (es) 2013-10-30
DE60222687T2 (de) 2008-07-17
RU2004115332A (ru) 2005-04-20
ES2292819T3 (es) 2008-03-16
IL160968A0 (en) 2004-08-31
RU2338528C2 (ru) 2008-11-20
CO5390076A1 (es) 2004-04-30
SI1438040T1 (sl) 2008-04-30
US20050013859A1 (en) 2005-01-20
PE20030476A1 (es) 2003-07-30
ATE374023T1 (de) 2007-10-15
US20120237601A1 (en) 2012-09-20
AR036813A1 (es) 2004-10-06
PT1438040E (pt) 2008-01-02
BR0213355A (pt) 2006-05-23
HU231114B1 (hu) 2020-09-28
NO341804B1 (no) 2018-01-22
CY1107841T1 (el) 2013-06-19
RU2007130786A (ru) 2009-02-20
EP1438040B1 (en) 2007-09-26
NZ532280A (en) 2007-05-31
HK1067861A1 (en) 2005-04-22
MY139206A (en) 2009-08-28
DK1438040T4 (da) 2020-01-27
ECSP024342A (es) 2003-03-10
TWI333861B (en) 2010-12-01
CN1310640C (zh) 2007-04-18
KR20050037409A (ko) 2005-04-21
PL415001A1 (pl) 2016-02-29
KR100671367B1 (ko) 2007-01-19
CA2460574A1 (en) 2003-04-24
MXPA04003636A (es) 2004-07-27
DE60222687T3 (de) 2020-03-05
GB0124953D0 (en) 2001-12-05
DK1438040T3 (da) 2008-02-04
ECSP024341A (es) 2003-12-01
EP1438040A1 (en) 2004-07-21
JP2005508959A (ja) 2005-04-07
JP2009137996A (ja) 2009-06-25
HUP0600451A2 (en) 2006-09-28
RU2381026C2 (ru) 2010-02-10
PL234541B1 (pl) 2020-03-31
IL160968A (en) 2016-04-21
DE60222687D1 (de) 2007-11-08
EP1438040B2 (en) 2019-10-16
CN1564684A (zh) 2005-01-12
PL367738A1 (en) 2005-03-07
SI1438040T2 (sl) 2020-02-28
US20100210717A1 (en) 2010-08-19
ES2292819T5 (es) 2020-05-29
ZA200401977B (en) 2006-05-31
AU2002338897B2 (en) 2006-10-19
WO2003032978A1 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
NO20041785L (no) Farmasoytisk sammensetning som innbefatter mykofenolsyre eller mykofenolatsalt
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
FI20011478L (fi) Farmaseuttinen koostumus
NO20033384L (no) Farmasoytisk formulering
DK1395242T3 (da) Flydende farmaceutisk sammensætning
DK1448195T3 (da) N-adamantylmethylderivater og mellemprodukter som farmaceutiske præparater og fremgangsmåde til fremstilling deraf
NO20033785L (no) Farmasöytisk formulering
PL375874A1 (pl) Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
MXPA03001329A (es) Metodo para la preparacion de citalopram.
NO20035627D0 (no) Farmasöytisk formulering
IS7051A (is) Lyfjasamsetningar
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
EP1408896A4 (en) PHARMACEUTICAL COMPOSITION
FI20022128A7 (fi) Farmaseuttinen koostumus
ITMI20011637A0 (it) Composizione farmaceutica contenente citalopram
ITMI20001695A0 (it) Procedimento per la preparazione di composizioni organico-sili-coniche.
NO20032957D0 (no) Farmasöytisk emulsjonspreparat
NO20033073D0 (no) Farmasöytisk sammensetning inneholdende citalopram
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
DE60042203D1 (de) Emulsionszusammensetzungen vom typ oel-in-wasser
ITRM20010579A1 (it) Composizione farmaceutica naturale contro la varroasi.
DK1289514T3 (da) Anvendelse af substituerede 1-amino-5-phenylpentan-3-ol- og/eller 1-amino-6-phenylhexan-3-ol-forbindelser som lægemidler
NO20043717L (no) Dihydrotiafenantren-karbonylguanidiner, fremgangsmate for fremstilling derav, deres anvendelse som medikament eller diagnostikum
NO20041236L (no) Farmasoytisk formulering
FI5468U1 (fi) Farmaseuttinen koostumus

Legal Events

Date Code Title Description
MK1K Patent expired